These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 11174239)

  • 1. Recurrence phenomena after immunoglobulin therapy for snake envenomations: Part 2. Guidelines for clinical management with crotaline Fab antivenom.
    Boyer LV; Seifert SA; Cain JS
    Ann Emerg Med; 2001 Feb; 37(2):196-201. PubMed ID: 11174239
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recurrence phenomena after immunoglobulin therapy for snake envenomations: Part 1. Pharmacokinetics and pharmacodynamics of immunoglobulin antivenoms and related antibodies.
    Seifert SA; Boyer LV
    Ann Emerg Med; 2001 Feb; 37(2):189-95. PubMed ID: 11174238
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Conservative management of delayed, multicomponent coagulopathy following rattlesnake envenomation.
    Camilleri C; Offerman S; Gosselin R; Albertson T
    Clin Toxicol (Phila); 2005; 43(3):201-6. PubMed ID: 15902796
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recurrent coagulopathy with delayed significant bleeding after crotaline envenomation.
    O'Brien NF; DeMott MC; Suchard JR; Clark RF; Peterson BM
    Pediatr Emerg Care; 2009 Jul; 25(7):457-9. PubMed ID: 19606002
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy, safety, and use of snake antivenoms in the United States.
    Dart RC; McNally J
    Ann Emerg Med; 2001 Feb; 37(2):181-8. PubMed ID: 11174237
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recurrent coagulopathy and thrombocytopenia in children treated with crotalidae polyvalent immune fab: a case series.
    Miller AD; Young MC; DeMott MC; Ly BT; Clark RF
    Pediatr Emerg Care; 2010 Aug; 26(8):576-82. PubMed ID: 20693856
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recurrent coagulopathy after antivenom treatment of crotalid snakebite.
    Bogdan GM; Dart RC; Falbo SC; McNally J; Spaite D
    South Med J; 2000 Jun; 93(6):562-6. PubMed ID: 10881769
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rattlesnake envenomation with neurotoxicity refractory to treatment with crotaline Fab antivenom.
    Richardson WH; Goto CS; Gutglass DJ; Williams SR; Clark RF
    Clin Toxicol (Phila); 2007; 45(5):472-5. PubMed ID: 17503249
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tracheal intubation prevented with administration of Fab antivenom after severe crotaline envenomation.
    Bebarta VS; Ferre RM; Peck M
    J Emerg Med; 2010 Jul; 39(1):e81-3. PubMed ID: 18722730
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recurrent and persistent coagulopathy following pit viper envenomation.
    Boyer LV; Seifert SA; Clark RF; McNally JT; Williams SR; Nordt SP; Walter FG; Dart RC
    Arch Intern Med; 1999 Apr; 159(7):706-10. PubMed ID: 10218750
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Clinical and biological surveillance of envenomed patients].
    Mion G; Olive F; Giraud D; Lambert E; Descraques C; Garrabé E; Goyffon M
    Bull Soc Pathol Exot; 2002 Aug; 95(3):139-43. PubMed ID: 12404854
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Crotalidae polyvalent immune Fab for the treatment of pediatric crotaline envenomation.
    Goto CS; Feng SY
    Pediatr Emerg Care; 2009 Apr; 25(4):273-9; quiz 280-2. PubMed ID: 19369845
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of F(ab')2 versus Fab antivenom for pit viper envenomation: a prospective, blinded, multicenter, randomized clinical trial.
    Bush SP; Ruha AM; Seifert SA; Morgan DL; Lewis BJ; Arnold TC; Clark RF; Meggs WJ; Toschlog EA; Borron SW; Figge GR; Sollee DR; Shirazi FM; Wolk R; de Chazal I; Quan D; García-Ubbelohde W; Alagón A; Gerkin RD; Boyer LV
    Clin Toxicol (Phila); 2015 Jan; 53(1):37-45. PubMed ID: 25361165
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Late hematologic toxicity following treatment of rattlesnake envenomation with crotalidae polyvalent immune Fab antivenom.
    Ruha AM; Curry SC; Albrecht C; Riley B; Pizon A
    Toxicon; 2011 Jan; 57(1):53-9. PubMed ID: 20920516
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Coagulation parameters in copperhead compared to other Crotalinae envenomation: secondary analysis of the F(ab')
    Gerardo CJ; Vissoci JR; Brown MW; Bush SP
    Clin Toxicol (Phila); 2017 Feb; 55(2):109-114. PubMed ID: 27806644
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Crotalidae polyvalent immune Fab (ovine) antivenom is effective in the neutralization of South American viperidae venoms in a murine model.
    Richardson WH; Tanen DA; Tong TC; Betten DP; Carstairs SD; Williams SR; Cantrell FL; Clark RF
    Ann Emerg Med; 2005 Jun; 45(6):595-602. PubMed ID: 15940091
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Out-of-hospital and interhospital management of crotaline snakebite.
    McKinney PE
    Ann Emerg Med; 2001 Feb; 37(2):168-74. PubMed ID: 11174235
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Short-term outcomes after Fab antivenom therapy for severe crotaline snakebite.
    Lavonas EJ; Kokko J; Schaeffer TH; Mlynarchek SL; Bogdan GM; Dart RC
    Ann Emerg Med; 2011 Feb; 57(2):128-137.e3. PubMed ID: 20952098
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recurrent hemorrhage after western diamondback rattlesnake envenomation treated with crotalidae polyvalent immune fab (ovine).
    Fazelat J; Teperman SH; Touger M
    Clin Toxicol (Phila); 2008 Nov; 46(9):823-6. PubMed ID: 18608290
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Subacute coagulopathy in a randomized, comparative trial of Fab and F(ab')2 antivenoms.
    Boyer LV; Chase PB; Degan JA; Figge G; Buelna-Romero A; Luchetti C; Alagón A
    Toxicon; 2013 Nov; 74():101-8. PubMed ID: 23948058
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.